25.02.2013 Views

AFI 11-2C-130v3 - BITS

AFI 11-2C-130v3 - BITS

AFI 11-2C-130v3 - BITS

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

268 <strong>AFI</strong><strong>11</strong>-<strong>2C</strong>-130V3 23 APRIL 2012<br />

20.10.3. Cargo will not be bumped except in unusual/abnormal cases, and only after the<br />

MCD has coordinated with the PIC and notified the tasking AE command element.<br />

20.10.4. Do not move ambulatory patients to litters in order to provide seating for additional<br />

patients or passengers.<br />

20.10.5. Patient Therapeutic Liquid Oxygen (PTLOX) or Next Generation Patient<br />

Therapeutic Oxygen System (NPTLOX) may be transported for positioning and<br />

depositioning AE crews. A maximum of 25 PTLOX serviced units may be transported<br />

simultaneously without Hazmat certification. Processing through aerial port is not required.<br />

If shipping more than six PTLOX containers as cargo, do not cover with plastic. This will<br />

prevent potential high concentration of oxygen levels. WARNING: Ensure the cargo floor is<br />

free from any oil or petroleum products.<br />

20.10.6. AE Movement of Contaminated/Contagious Personnel. It is United States<br />

Transportation Command (USTRANSCOM) policy that patients personnel, or casualties<br />

with known or suspected contamination from chemical, biological, or nuclear warfare agents<br />

will not be transported within the aeromedical patient movement system. Decontamination<br />

must be performed prior to transport to prevent the potential spread of contamination. In rare<br />

cases, transport may be essential to preserve life or continue critical missions. If such<br />

transport is deemed essential, all efforts must be made to prevent the spread of<br />

contamination. In these cases, prior approval must be given by the involved geographic<br />

combatant commanders, Commander USTRANSCOM, and the Secretary of Defense<br />

(SECDEF) in consultation with Department of Defense medical authorities.<br />

20.10.6.1. Patients with known or suspected or highly contagious disease will not be<br />

transported within the patient movement system. These include infections with any agent<br />

that may pose a potential threat to national security, require special public health actions,<br />

and/or have the potential to cause public panic and social disruption. Patients known or<br />

suspected to be infected with a highly contagious disease should be treated ―in place‖ or<br />

with minimal transportation to medical authorities. In extreme circumstances there may<br />

be a requirement to move index cases (approximately two) for evaluation or critical<br />

medical care. If patient movement is required, prior approval must be given by the<br />

involved geographic combatant commanders, Commander USTRANSCOM, and<br />

SECDEF in consultation with medical authorities.<br />

20.10.6.2. AMC will train and equip AE crews and stage required equipment at key hubs<br />

to carry out these limited missions for movement of contaminated and contagious<br />

patients. NOTE: If AECMs are utilizing the MCU-2A ground chemical mask, a FL<br />

below 10,000 feet is recommended due to reported valve failure during rapid<br />

decompression.<br />

20.10.7. Hazardous cargo will not normally be transported aboard AE missions except in<br />

extreme circumstances.<br />

20.<strong>11</strong>. Crash/Fire/Rescue (CFR).<br />

20.<strong>11</strong>.1. Aircraft carrying patient(s) will be provided CFR protection per TO 00-25-172.<br />

When concurrent fuel servicing with patients/passengers on board a major aircraft rescue and<br />

fire vehicle will be available to respond within three minutes or as determined by the base

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!